David Zahrieh

6.0k total citations
71 papers, 4.3k citations indexed

About

David Zahrieh is a scholar working on Oncology, Hematology and Cancer Research. According to data from OpenAlex, David Zahrieh has authored 71 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 16 papers in Hematology and 16 papers in Cancer Research. Recurrent topics in David Zahrieh's work include Breast Cancer Treatment Studies (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). David Zahrieh is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). David Zahrieh collaborates with scholars based in United States, Italy and Switzerland. David Zahrieh's co-authors include Donna Neuberg, Richard D. Gelber, John G. Gribben, Edwin P. Alyea, Robert J. Soiffer, Aron Goldhirsch, Monica Castiglione‐Gertsch, Stephanie J. Lee, Karen N. Price and Joseph H. Antin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Investigation.

In The Last Decade

David Zahrieh

68 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Zahrieh United States 32 1.7k 1.1k 1.1k 896 875 71 4.3k
Yago Nieto United States 34 1.7k 1.0× 604 0.5× 1.9k 1.7× 440 0.5× 594 0.7× 242 4.0k
Hartmut Kirchner Germany 32 1.9k 1.1× 638 0.6× 1.0k 1.0× 997 1.1× 1.7k 2.0× 117 5.0k
J Garcı́a-Conde Spain 35 2.0k 1.2× 584 0.5× 984 0.9× 425 0.5× 1.1k 1.3× 104 3.9k
Nikolas von Bubnoff Germany 31 1.1k 0.7× 537 0.5× 2.0k 1.8× 444 0.5× 481 0.5× 138 4.1k
Michael L. Grossbard United States 37 2.3k 1.4× 340 0.3× 482 0.5× 981 1.1× 1.8k 2.1× 120 4.7k
Liqiang Xi United States 42 2.0k 1.2× 1.4k 1.3× 248 0.2× 747 0.8× 1.4k 1.6× 125 5.7k
Ullrich Graeven Germany 34 2.9k 1.7× 426 0.4× 644 0.6× 1.1k 1.2× 747 0.9× 135 4.4k
Stefan Hohaus Italy 39 1.4k 0.8× 430 0.4× 1.5k 1.4× 250 0.3× 1.0k 1.2× 167 4.2k
Lorenz Trümper Germany 42 3.3k 1.9× 850 0.8× 1.0k 1.0× 823 0.9× 3.9k 4.5× 203 7.5k
J. Thaler Austria 37 1.1k 0.6× 296 0.3× 1.1k 1.1× 490 0.5× 421 0.5× 125 4.1k

Countries citing papers authored by David Zahrieh

Since Specialization
Citations

This map shows the geographic impact of David Zahrieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Zahrieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Zahrieh more than expected).

Fields of papers citing papers by David Zahrieh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Zahrieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Zahrieh. The network helps show where David Zahrieh may publish in the future.

Co-authorship network of co-authors of David Zahrieh

This figure shows the co-authorship network connecting the top 25 collaborators of David Zahrieh. A scholar is included among the top collaborators of David Zahrieh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Zahrieh. David Zahrieh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Elizabeth, David Zahrieh, Selina Chow, et al.. (2023). Electronic Patient-Reported Outcome Data Collection Systems in Oncology Clinical Trials: A Survey of Clinical Research Professionals (an Alliance Study). JCO Clinical Cancer Informatics. 7(7). e2300007–e2300007. 1 indexed citations
2.
Zahrieh, David, Ivana T. Croghan, Jonathan Inselman, & Sumithra J. Mandrekar. (2023). Guidelines for Data and Safety Monitoring in Pragmatic Randomized Clinical Trials Using Case Studies. Mayo Clinic Proceedings. 98(11). 1712–1726. 1 indexed citations
3.
Cathcart-Rake, Elizabeth, David Zahrieh, Susan E. Young, et al.. (2023). A five arm natural history study of nasal vestibulitis. Cancer Medicine. 12(8). 9650–9654. 1 indexed citations
4.
5.
Zahrieh, David, Daniel Satele, Elizabeth Smith, Charles L. Loprinzi, & Jennifer Le‐Rademacher. (2022). Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months. Cancers. 14(5). 1212–1212. 2 indexed citations
6.
Thompson, Kevin J., Roberto A. Leon‐Ferre, Jason P. Sinnwell, et al.. (2022). Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response. NAR Cancer. 4(2). zcac018–zcac018. 26 indexed citations
7.
Carter, Jodi M., Mei‐Yin C. Polley, Roberto A. Leon‐Ferre, et al.. (2021). Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer. Clinical Cancer Research. 27(20). 5628–5637. 35 indexed citations
8.
Wood, Marie, Heshan Liu, David Zahrieh, et al.. (2021). The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial. Cancer Prevention Research. 14(7). 753–762. 6 indexed citations
9.
Zahrieh, David, Michael A. Golafshar, Samir H. Patel, & T.A. DeWees. (2021). Quantification of Potential Inequities in Breast Cancer Incidence in New Mexico Through Bayesian Disease Mapping. Preventing Chronic Disease. 18. E23–E23. 3 indexed citations
10.
He, Jun, et al.. (2021). Does the placebo effect on hot flashes depend on the placebo dose?. Supportive Care in Cancer. 29(11). 6741–6749. 1 indexed citations
11.
Wheeler, Philip H., Chung‐Il Wi, Chris Derauf, et al.. (2020). Mobile home residence as a risk factor for adverse events among children in a mixed rural–urban community: A case for geospatial analysis. SHILAP Revista de lepidopterología. 4(5). 443–450. 4 indexed citations
12.
Ruddy, Kathryn J., Janet E. Olson, Fergus J. Couch, et al.. (2020). Real-world experiences with acupuncture among breast cancer survivors: a cross-sectional survey study. Supportive Care in Cancer. 28(12). 5833–5838. 6 indexed citations
13.
Carrel, Margaret, David Zahrieh, Sean G. Young, et al.. (2017). High prevalence of elevated blood lead levels in both rural and urban Iowa newborns: Spatial patterns and area-level covariates. PLoS ONE. 12(5). e0177930–e0177930. 22 indexed citations
14.
Colleoni, Marco, Giuseppe Viale, David Zahrieh, et al.. (2007). Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy. Annals of Oncology. 19(3). 465–472. 82 indexed citations
15.
Dileo, Palma, Jeffrey A. Morgan, David Zahrieh, et al.. (2007). Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas. Cancer. 109(9). 1863–1869. 56 indexed citations
16.
Zirlik, Katja, David Zahrieh, Donna Neuberg, & John G. Gribben. (2006). Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide. Blood. 108(12). 3865–3870. 31 indexed citations
17.
Bernhard, Jürg, David Zahrieh, Monica Castiglione‐Gertsch, et al.. (2006). Adjuvant Chemotherapy Followed By Goserelin Compared With Either Modality Alone: The Impact on Amenorrhea, Hot Flashes, and Quality of Life in Premenopausal Patients—The International Breast Cancer Study Group Trial VIII. Journal of Clinical Oncology. 25(3). 263–270. 47 indexed citations
18.
Rudenstam, Carl‐Magnus, David Zahrieh, John Forbes, et al.. (2005). Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93. Journal of Clinical Oncology. 24(3). 337–344. 297 indexed citations
19.
Colleoni, Marco, Giuseppe Viale, David Zahrieh, et al.. (2004). Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors. Clinical Cancer Research. 10(19). 6622–6628. 282 indexed citations
20.
Mutter, George L., David Zahrieh, Chunmei Liu, et al.. (2004). Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression microarrays. BMC Genomics. 5(1). 88–88. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026